Τίτλος:
Oral Complications of Head and Neck Cancer Therapy
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Current therapies for Head and Neck cancer treatment are extremely advanced. Though, they cause oral complications which have deleterious effects on basic life functions, affect oral and overall health, may lead to significant morbidity and treatment discontinuation and have an impact on survivorship and quality of life. As new therapies are introduced, a new spectrum of oral complications is rising, compromising the mucosal integrity and the salivary function, that may not be recognized, reported and treated properly. Oral complications, often permanent and extremely painful, may include mucositis, xerostomia, dysgeusia, infections, trismus and fibrosis, risk of dental disease and necrosis of the jaw, neurosensory disorders and when targeted therapies and immunotherapy are involved, aphthoid and lichenoid lesions can also be reported. Increased awareness is required for the prevention and management of these complications, which can be best provided by a multidisciplinary team. © 2021 Maria Kouri et al., published by Sciendo 2021.
Συγγραφείς:
Kouri, M.
Vadalouca, A.
Kouloulias, V.
Papadopoulou, E.
Vardas, E.
Kyrodimos, E.
Trichas, M.
Galitis, E.
Zygogianni, A.
Liakouli, Z.
Nicolatou-Galitis, O.
Psyrri, A.
Περιοδικό:
Forum of Clinical Oncology
Εκδότης:
De Gruyter Open Ltd
Λέξεις-κλειδιά:
alpha tocopherol; amifostine; analgesic agent; antibiotic agent; antifungal agent; antihistaminic agent; antineoplastic agent; antivirus agent; botulinum toxin; cannabinoid; clonazepam; emollient agent; fluoride prophylaxis toothpaste; gabapentin; megestrol; mouthwash; muscarinic agent; pentoxifylline; pregabalin; steroid, aphthoid lesion; aphthoid lesion; bacterial infection; cancer therapy; dysgeusia; fibrosis; head and neck cancer; herpetic stomatitis; human; jaw osteonecrosis; lichenoid; medication related osteonecrosis of the jaw; mouth disease; mouth pain; nonhuman; oral mucositis; osteoradionecrosis; patient care; Review; steroid therapy; thrush; tooth disease; trismus; xerostomia
DOI:
10.2478/fco-2019-0016
